PGEN
PRECIGEN, INC.Company Information
- Company Name
- PRECIGEN, INC.
- CIK
- CIK0001356090
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PGEN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PGEN
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-21
- Last sale
- 2026-08-26
- Shares purchased (TTM)
- 39,988
- Shares sold (TTM)
- 14,629,436
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 140,961,650
- Shares outstanding
- 356,893,568
- Ownership
- 39.50%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 6.43%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 16 | 7 | 30 | 14 | 14 | 6 | 30 | 25 | 9 | 17 | 8 | 10 | ||||||
| Short Term Investments | 22 | 49 | 68 | 107 | 46 | 74 | 68 | 4 | 10 | 27 | 55 | 64 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Receivables Net Current | ||||||||||||||||||
| Accounts Receivable Net Current | 72 | 26 | 4 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 13 | ||||||
| Inventory Gross | 20 | 15 | 10 | 3 | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 3 | 4 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 5 | ||||||
| Assets Current | 134 | 102 | 115 | 130 | 63 | 85 | 102 | 35 | 24 | 50 | 69 | 93 | ||||||
| Available For Sale Securities Debt Securities Noncurrent | 0 | 0 | 3 | 3 | - | 1 | 0 | - | - | - | - | 5 | ||||||
| Property Plant And Equipment Net | 13 | 13 | 14 | 15 | 15 | 15 | 14 | 14 | 13 | 13 | 7 | 7 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 39 | 41 | 40 | ||||||
| Goodwill | 15 | 15 | 15 | 15 | 15 | 19 | 19 | 25 | 25 | 27 | 27 | 37 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Assets | 170 | 139 | 156 | 171 | 102 | 129 | 145 | 83 | 73 | 135 | 151 | 191 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 5 | 3 | 12 | 6 | 4 | 3 | 4 | 4 | 5 | 5 | 2 | 2 | ||||||
| Employee Related Liabilities Current | 6 | 5 | 10 | 10 | 5 | 10 | 8 | 7 | 7 | 10 | 8 | 7 | ||||||
| Other Accrued Liabilities Current | 16 | 12 | 11 | 11 | 10 | 7 | 5 | 6 | 7 | 7 | 6 | 4 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities Current | 29 | 21 | 37 | 32 | 23 | 24 | 22 | 21 | 23 | 29 | 23 | 33 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | 0 | 0 | 0 | 2 | 2 | 2 | ||||||
| Long Term Debt | - | 94 | - | 93 | - | - | - | - | - | - | - | - | ||||||
| Long Term Debt Noncurrent | 94 | 94 | 93 | - | - | - | 0 | - | - | - | - | - | ||||||
| Contract With Customer Liability Noncurrent | - | - | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Noncurrent | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Warrants And Rights Outstanding | - | - | 0 | 0 | - | - | 51 | - | - | - | - | - | ||||||
| Liabilities | 127 | 118 | 135 | 129 | 108 | 113 | 79 | 28 | 30 | 38 | 33 | 43 | ||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | - | - | 0 | 0 | 31 | 30 | 28 | - | - | - | 0 | - | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 2,373 | 2,370 | 2,362 | 2,360 | 2,135 | 2,131 | 2,129 | 2,126 | 2,093 | 2,088 | 2,085 | 2,083 | ||||||
| Retained Earnings Accumulated Deficit | -2,329 | -2,349 | -2,341 | -2,318 | -2,172 | -2,145 | -2,091 | -2,071 | -2,047 | -1,988 | -1,964 | -1,931 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | -3 | -2 | -4 | ||||||
| Stockholders Equity | 44 | 20 | 21 | 42 | -37 | -14 | 39 | 55 | 43 | 97 | 118 | 148 | ||||||
| Preferred Stock Shares Authorized | - | - | 25 | - | - | 25 | 25 | - | - | - | 25 | - | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Liquidation Preference Value | - | - | - | - | - | 81 | 79 | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 170 | 139 | 156 | 171 | 102 | 129 | 145 | 83 | 73 | 135 | 151 | 191 | ||||||
| Series A Preferred Stock | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Authorized | - | - | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Temporary Equity Shares Issued | - | - | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Temporary Equity Liquidation Preference | - | - | 0 | 0 | 82 | - | 79 | - | - | - | - | - | ||||||
| Common Stock No Par Value | 0 | 0 | - | - | 0 | 0 | - | 0 | 0 | 0 | - | 0 | ||||||
| Common Stock Shares Authorized | 700 | 700 | 700 | 700 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | ||||||
| Common Stock Shares Issued | 358 | 356 | 354 | 354 | 298 | 295 | 293 | 293 | 256 | 256 | 256 | 256 | ||||||
| Shares Outstanding | 358 | 356 | 354 | 354 | 298 | 295 | 293 | 293 | 253 | 250 | 249 | 256 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPRECIGEN, INC. (PGEN) — SEC Financial Statements & Analysis
PRECIGEN, INC. (PGEN) is a pharmaceutical preparations company, incorporated in VA. PRECIGEN, INC. trades on Nasdaq as: PGEN. PRECIGEN, INC. (PGEN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, PRECIGEN, INC. carries a market cap of $2.03B, a P/E ratio of -6.04x, a P/B ratio of 46.68x, a P/S ratio of 23.73x, an enterprise value of $2.11B, and an EV/EBITDA multiple of -59.73x. On profitability, it posts a gross margin of 90.67%, an operating margin of -46.08%, a net margin of -392.81%, a Return on Equity (ROE) of -9907.46%, a Return on Assets (ROA) of -247.40%, and a Return on Invested Capital (ROIC) of -109.08%. Per share, it reports EPS of $-0.94, diluted EPS of $-0.81, free cash flow per share of $-0.32, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 1339.90% year-over-year, net income growth of 170.45% year-over-year, and EPS growth of 124.63% year-over-year. On the balance sheet, it maintains a current ratio of 4.58x, a quick ratio of 3.76x, working capital of $105.03M, a debt-to-equity ratio of 2.91x, a debt ratio of 0.74, an interest coverage ratio of -4.06x, free cash flow of $-115.22M (TTM), and net debt of $77.55M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.03B
- P/E TTM
- -6.04x
- EPS TTM
- $-0.94
- P/B TTM
- 46.68x
- ROE TTM
- -9907.46%
- ROA TTM
- -247.40%
- Debt To Equity
- 2.91x
- Free Cash Flow TTM
- $-115.22M
- Net Revenue TTM Growth 1Y
- 1339.90%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PRECIGEN, INC. in?
PRECIGEN, INC. (PGEN) operates in the Pharmaceutical Preparations industry.
What exchange does PGEN trade on?
PRECIGEN, INC. (PGEN) trades on the Nasdaq.
Where is PRECIGEN, INC. incorporated?
PRECIGEN, INC. is incorporated in VA.
When was PRECIGEN, INC. (PGEN)'s most recent SEC filing?
PRECIGEN, INC. (PGEN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is PGEN's market cap?
PRECIGEN, INC. (PGEN) has a market capitalization of $2.03B as of 2026-06-30.
What is PGEN's EPS (earnings per share)?
PRECIGEN, INC. (PGEN)'s trailing twelve month EPS is $-0.94 as of 2026-06-30.
What is PGEN's ROE (return on equity)?
PRECIGEN, INC. (PGEN)'s trailing twelve month Return on Equity (ROE) is -9907.46% as of 2026-06-30.
What is PGEN's ROA (return on assets)?
PRECIGEN, INC. (PGEN)'s trailing twelve month Return on Assets (ROA) is -247.40% as of 2026-06-30.
What is PGEN's ROIC (return on invested capital)?
PRECIGEN, INC. (PGEN)'s trailing twelve month Return on Invested Capital (ROIC) is -109.08% as of 2026-06-30.
What is PGEN's EV/EBITDA?
PRECIGEN, INC. (PGEN)'s trailing twelve month EV/EBITDA is -59.73x as of 2026-06-30.